Novo Nordisk sues Eli Lilly over weight-loss ads citing outdated trial data
The lawsuit alleges Lilly's Zepbound and Mounjaro marketing leans on stale evidence to exaggerate efficacy versus rivals.
By Mohammed Al-Shehri·· 3 min

Curating from trusted global sources…
17 briefings · “ads”
The lawsuit alleges Lilly's Zepbound and Mounjaro marketing leans on stale evidence to exaggerate efficacy versus rivals.

A court filing asks to block Lilly’s GLP-1 advertising and force corrections, raising the heat on drug marketing scrutiny.

A satirical movement is mutating into a broader youth reckoning, pressuring policymakers on education and employment.

An Arm64 upstream push could reshape SteamOS 3, Steam Linux share, and how quickly gaming moves to new silicon.

A fixed $135 IPO roadshow price would put SpaceX at $1.75 trillion, a milestone that reshuffles how founders, boards, and public-market investors compare private and listed giants.